Highlights Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
5.5 ^USD	-19.24%		-11.29%	-67.84%

Apr. 24	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	CI
Mar. 26	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG	Apr. 24	CI
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients	Mar. 26	CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 14	CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 14	CI
Heart Test Laboratories, Inc. Enters into Multiple Definitive License Agreements with Icahn School of Medicine At Mount Sinai	Dec. 06	CI
HeartSciences Completes License Agreements on AI Cardiovascular Algorithms With Icahn School of Medicine at Mount Sinai	Nov. 20	MT
Heart Test Laboratories, Inc. Announces That Its Myovista® Wavecgtm Has Been Selected by Cardiact Ltd (?Cardiact?) to Be Used in Its Heart Screening Program of Members of the Association of Garda Sergeants and Inspectors	Nov. 13	CI
Heart Test Laboratories, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-14	CI
Heart Test Laboratories Has Distribution Accord With Denmark's FJ Medical	23-08-31	MT
Heart Test's MyoVista wavECG Selected by PanaceaFlo for Heart Screening Evaluation Study in Dublin	23-08-24	MT
Heart Test Laboratories, Inc. Announces It?s MyoVista wavECGTM Selection to Be Used in Irish Heart Screening Evaluation	23-08-24	CI
Heart Test Laboratories Gets Patent Allowance Notice From European Patent Office	23-08-17	MT
Heart Test Laboratories, Inc. Announces Further Expansion of Artificial Intelligence Patent Portfolio	23-08-17	CI
Heart Test Laboratories, Inc Announces MyoVista® wavECGTM Selects for Commercial Use in Clinical Practice by the Naya Imaging Center in Hvidore, Denmark	23-07-27	CI
Heart Test Laboratories, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-07-19	CI
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results	23-03-16	GL
HEART TEST LABORATORIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-03-16	AQ
Heart Test Laboratories Receives Israeli Patent for MyoVista Wavelet	23-02-06	MT
Heart Test Laboratories Receives South Korean Patent for MyoVista	23-02-03	MT
HEART TEST LABORATORIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-12-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Heart Test Laboratories, Inc.

Equities

HSCS

US42254E3027

Highlights

Filters